Dr. Pavle Doroslovacki, MD

  • Pittsburgh, PA
  • Ophthalmic plastic and reconstructive surgery physician
NPI1508182346PAC ID6103076005
Medicare services, 2024
854
Medicare patients, 2024
511
Part D claims, 2024
999
Publications
2
MIPS score, 2024
94
Practice address
1400 Locust Street, Pittsburgh, PA 15219
Practice phone
Call (412) 232-8111
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Primary practice

UPMC Mercy

Hospital · Pittsburgh, Pennsylvania

See all 5 affiliations

Find Dr. Doroslovacki's professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

Dr. Pavle Doroslovacki is an ophthalmic plastic and reconstructive surgery physician in Pittsburgh, Pennsylvania

Dr. Doroslovacki practices at UPMC Mercy in Pittsburgh, Pennsylvania, part of University of Pittsburgh Medical Center.

Dr. Doroslovacki's NPI, 1508182346, was assigned on April 19, 2010. Dr. Doroslovacki graduated from Johns Hopkins University School of Medicine in 2010. Dr. Doroslovacki holds Pennsylvania license MD447548.

NPI and contact details
Medicare PAC ID
6103076005
NPI enumeration date
April 19, 2010
NPI status
Active
Accepts Medicare assignment
Yes
Practice phone
(412) 232-8111
Professional email
Get email
Personal email
Get email
Mobile number
Get number
Sex
Male
Estimated age
42
Medical school graduation
2010

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)

Dr. Pavle Doroslovacki practices at UPMC Mercy in Pittsburgh, Pennsylvania

Dr. Doroslovacki's primary practice is UPMC Mercy, at 1400 Locust Street, Pittsburgh, PA 15219 in Allegheny County. The practice phone is (412) 232-8111.

  • UPMC Mercy
    1400 Locust Street, Pittsburgh, PA 15219 · Allegheny CountyPhone(412) 232-8111

Source: Dmand AI Affiliation Data

Dr. Pavle Doroslovacki is affiliated with 3 sites of care and 2 medical groups

Dr. Doroslovacki's primary practice is UPMC Mercy in Pittsburgh, Pennsylvania, part of University of Pittsburgh Medical Center. Dr. Doroslovacki is also affiliated with UPMC St. Margaret. The medical group on file is University of Pittsburgh Physicians, Department of Radiology. Dmand AI also links Dr. Doroslovacki to 1 more therapy and rehab clinic and 1 medical group, each named with a free account.

See all 5 affiliations for Dr. Doroslovacki

Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data

Dmand AI tracks the EHR system at Dr. Pavle Doroslovacki's practice

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Doroslovacki practices, 3 sites in all. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
UPMC MercyAvailable with a free account
+2 more sites and 1 medical groupAvailable with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every hospital where Dr. Doroslovacki practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across University of Pittsburgh Medical Center and 6.2K+ hospitals, with verified contacts in the same login.

Dr. Pavle Doroslovacki is one of 18 ophthalmic plastics and reconstructive surgery physicians in Pennsylvania

Ophthalmic plastic and reconstructive surgery is Dr. Doroslovacki's primary specialty in the NPI Registry, under taxonomy code 207WX0200X. Dr. Doroslovacki is licensed in Pennsylvania.

Specialties and state licenses

  • Ophthalmic plastic and reconstructive surgery, PennsylvaniaPrimaryLicense MD447548 · taxonomy 207WX0200X

Ophthalmic plastics and reconstructive surgery physicians near Dr. Doroslovacki

Counts of ophthalmic plastics and reconstructive surgery physicians with a Dmand AI profile, by place and practice. Each opens the list.

18ophthalmic plastics and reconstructive surgery physicians in Pennsylvania
2ophthalmic plastics and reconstructive surgery physicians in Pittsburgh

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

Dr. Pavle Doroslovacki billed Medicare for 854 services in 2024

CMS data shows 854 Medicare services from Dr. Doroslovacki across 11 procedure codes in 2024, for 511 Medicare patients. Medicare paid $57,285 for them. Every service was in an office.

Medicare services, 2024854
Medicare patients511
Paid by Medicare$57,285
Procedure codes11

Dr. Doroslovacki's Medicare services by type, 2023 to 2024

  • 2023
  • 2024
Tests and treatments
2023: 1,1812024: 82830%
Surgery
2023: 282024: 1450%
Office and hospital visits
2023: 02024: 12

Dr. Doroslovacki compared with the Pennsylvania median for ophthalmic plastics and reconstructive surgery physicians, 2024

  • Dr. Doroslovacki
  • Pennsylvania median
Medicare services
854vs 47381% above
Medicare patients
511vs 26097% above
Part D claims
912vs 46696% above

Medians across 16 ophthalmic plastics and reconstructive surgery physicians in Pennsylvania with Dmand AI profiles that report each measure.

Dr. Doroslovacki's most billed Medicare procedure codes, 2024

CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.

See all procedures by Dr. Doroslovacki

Need commercial claims for Dr. Doroslovacki?

Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Doroslovacki and other ophthalmic plastics and reconstructive surgery physicians in Pennsylvania.

Book a meeting

Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks

Dr. Pavle Doroslovacki treated 511 Medicare patients in 2024, average age 75

CMS counts 511 Medicare patients who saw Dr. Doroslovacki in 2024. The largest group is 65 to 74, with 209 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 17% are also on Medicaid. Their average risk score is 1.24, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Doroslovacki's median patient age at 70, with 57% women.

Medicare patients, 2024511
Average age75
Average risk score1.24
Also on Medicaid17%

Dr. Doroslovacki's Medicare patients by age, 2024

Dr. Doroslovacki's Medicare patients by sex, 2024

  • Women31161%
  • Men20039%

Chronic conditions among Dr. Doroslovacki's Medicare patients, 2024

  1. High blood pressure75%
  2. High cholesterol75%
  3. Arthritis53%
  4. Diabetes44%
  5. Chronic kidney disease28%
  6. Ischemic heart disease23%
  7. Mood disorders19%
  8. Atrial fibrillation16%

Share of Medicare patients with each condition. A patient can have several.

Dr. Doroslovacki's patients across all payers

Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.

Patient panel by age, all payers

Median age 70

Patient panel by sex, all payers

  • Women57%
  • Men41%

Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data

Dr. Pavle Doroslovacki wrote 999 Medicare Part D claims in 2024

In 2024, Dr. Doroslovacki wrote 999 Medicare Part D claims for 314 patients. 84% of them were for generic drugs. CMS names the drug for 912 of them, across 11 drugs with 11 or more claims each, at $23,831 in total drug cost. In 2023, CMS named 669 claims across 10 drugs.

Part D claims, 2024999
Drugs named by CMS11
Total drug cost$23,831
Part D patients314

Dr. Doroslovacki's Part D claims by kind of drug, 2024

  • Generic840 claims84%
  • Brand-name159 claims16%

Dr. Doroslovacki's most prescribed drugs by claims, 2024

CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.

Part D claims for drugs CMS names, 2023 to 2024

  • 2023
  • 2024
Claims for drugs CMS names
2023: 6692024: 91236%

Drugs named by CMS: 11 in 2024, 10 in 2023.

See all prescribing by Dr. Doroslovacki

Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data

Dr. Pavle Doroslovacki scored 94 out of 100 in Medicare's MIPS program for 2024

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Dr. Doroslovacki for performance year 2024, reported as part of a group. Dr. Doroslovacki accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Accepts Medicare assignment
Yes

Dr. Doroslovacki's MIPS scores, performance year 2024

  • 94of 100Final score
  • 80.3of 100Quality
  • 100of 100Promoting Interoperability
  • 40of 100Improvement Activities
  • 75of 100Cost

Each score is out of 100. The final score weighs the categories CMS scored for this clinician.

Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026

For MedTech and pharma teams

Find ophthalmic plastics and reconstructive surgery physicians like Dr. Doroslovacki by procedure volume and prescribing

Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.

Dr. Pavle Doroslovacki has 2 publications on record

Dmand AI links 2 papers to Dr. Doroslovacki in 2015. Dr. Doroslovacki's most frequent co-author is Joseph Scheller, MD.

Papers2

Dr. Doroslovacki's most frequent co-authors

Recent publications by Dr. Doroslovacki

See all 2 publications and co-authors

See who Dr. Doroslovacki researches with

Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Doroslovacki works with, so you can find a warm path to the right ophthalmic plastics and reconstructive surgery physicians.

How network discovery works

Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage

Dr. Pavle Doroslovacki received $194 in industry payments from 2018 to 2025

CMS Open Payments shows 4 general payments to Dr. Doroslovacki from 4 drug and device companies from 2018 to 2025. Food and beverage make up the largest share, 100% of the total. Alexion Pharmaceuticals, Inc. paid the most, $88.

General payments to Dr. Doroslovacki by program year, 2018 to 2025

Companies that paid Dr. Doroslovacki the most, 2018 to 2025

Share is of all general payments to this clinician.

See all payments to Dr. Doroslovacki

Source: Open Payments (CMS), 2025 data, released July 7, 2026

Dr. Pavle Doroslovacki graduated from Johns Hopkins University School of Medicine

Dr. Doroslovacki graduated from Johns Hopkins University School of Medicine in 2010.

  1. Medical schoolJohns Hopkins University School of Medicine

Source: Dmand AI Professional Profile Data

Sources for Dr. Pavle Doroslovacki's profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Practice locations and phoneDmand AI Affiliation Data
Primary practice, affiliations and health systemDmand AI Affiliation DataDmand AI Org Hierarchy Data
Medicare services and procedure codesMedicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab)
State medians for the same specialtyDmand AI Peer Benchmarks
Medicare patients and the all-payer patient panelDmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab)
Part D prescribingMedicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab)
MIPS scores, telehealth, assignment and procedure percentilesDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab)
Publications, topics and co-authorsPubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage
Industry paymentsOpen Payments (CMS) (opens in a new tab)
Training, board certification and membershipsDmand AI Professional Profile Data
EHR at each practice siteDmand AI Technology Install Data
Similar physiciansDmand AI Affiliation Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about Dr. Pavle Doroslovacki

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is Dr. Pavle Doroslovacki's NPI number?

Dr. Pavle Doroslovacki's NPI number is 1508182346. It was assigned on April 19, 2010, and it is active in the NPI Registry.

What kind of doctor is Dr. Pavle Doroslovacki?

Dr. Pavle Doroslovacki is an ophthalmic plastic and reconstructive surgery physician in Pittsburgh, Pennsylvania. The primary specialty in the NPI Registry is Ophthalmic Plastic and Reconstructive Surgery Physician (taxonomy code 207WX0200X).

Where does Dr. Pavle Doroslovacki practice?

Dr. Doroslovacki practices at 1400 Locust Street, Pittsburgh, PA 15219. Dr. Doroslovacki's primary practice is UPMC Mercy in Pittsburgh, Pennsylvania, part of University of Pittsburgh Medical Center. Dmand AI also links Dr. Doroslovacki to 1 therapy and rehab clinic and 1 medical group.

What is Dr. Pavle Doroslovacki's office phone number?

The practice phone on file for Dr. Doroslovacki is (412) 232-8111.

What is Dr. Pavle Doroslovacki's medical license number?

Dr. Doroslovacki holds Pennsylvania license MD447548.

Which hospitals is Dr. Pavle Doroslovacki affiliated with?

Dr. Doroslovacki practices at UPMC Mercy in Pittsburgh, Pennsylvania. Dr. Doroslovacki is also affiliated with UPMC St. Margaret.

What medical group is Dr. Pavle Doroslovacki part of?

Dr. Doroslovacki is linked to University of Pittsburgh Physicians, Department of Radiology. Dmand AI links Dr. Doroslovacki to 1 more medical group.

Does Dr. Pavle Doroslovacki accept Medicare?

Yes. CMS data shows Dr. Doroslovacki billed Medicare for 854 services in 2024, and Dr. Doroslovacki accepts Medicare assignment.

What is Dr. Pavle Doroslovacki's MIPS score?

Dr. Doroslovacki's MIPS final score for performance year 2024 is 94 out of 100, reported as part of a group.

How many Medicare patients does Dr. Pavle Doroslovacki see?

CMS counts 511 Medicare patients who saw Dr. Doroslovacki in 2024, with an average age of 75.

Show 7 more questionsShow fewer questions

What services does Dr. Pavle Doroslovacki bill to Medicare?

In 2024, Dr. Doroslovacki's most billed Medicare services were eye exam or test (92014), eye exam or test (92012) and eye exam or test (92083).

Where did Dr. Pavle Doroslovacki go to medical school?

Dr. Doroslovacki graduated from Johns Hopkins University School of Medicine in 2010.

What drugs does Dr. Pavle Doroslovacki prescribe most?

In 2024 Medicare Part D data, Dr. Doroslovacki's most prescribed drugs by claims were Latanoprost, Azelastine HCl and Timolol Maleate.

Has Dr. Pavle Doroslovacki received payments from drug or device companies?

CMS Open Payments shows $194 in general payments to Dr. Doroslovacki from 4 companies from 2018 to 2025. The largest total came from Alexion Pharmaceuticals, Inc.

How long has Dr. Pavle Doroslovacki been practicing?

Dr. Doroslovacki graduated from medical school in 2010, 16 years ago.

Does Dr. Pavle Doroslovacki do research?

Dmand AI links 2 publications to Dr. Doroslovacki.

Who does Dr. Pavle Doroslovacki publish with?

Dr. Doroslovacki's most frequent co-authors are Joseph Scheller, MD (1 shared paper).

Selling to ophthalmic plastic and reconstructive surgery practices?

See ophthalmic plastics and reconstructive surgery physicians in Pennsylvania by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)